Success Metrics

Clinical Success Rate
72.7%

Based on 32 completed trials

Completion Rate
73%(32/44)
Active Trials
34(35%)
Results Posted
50%(16 trials)
Terminated
12(12%)

Phase Distribution

Ph phase_2
39
40%
Ph phase_3
3
3%
Ph early_phase_1
3
3%
Ph phase_4
2
2%
Ph not_applicable
14
14%
Ph phase_1
17
17%

Phase Distribution

20

Early Stage

39

Mid Stage

5

Late Stage

Phase Distribution78 total trials
Early Phase 1First-in-human
3(3.8%)
Phase 1Safety & dosage
17(21.8%)
Phase 2Efficacy & side effects
39(50.0%)
Phase 3Large-scale testing
3(3.8%)
Phase 4Post-market surveillance
2(2.6%)
N/ANon-phased studies
14(17.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

69.6%

32 of 46 finished

Non-Completion Rate

30.4%

14 ended early

Currently Active

34

trials recruiting

Total Trials

98

all time

Status Distribution
Active(38)
Completed(32)
Terminated(14)
Other(14)

Detailed Status

Completed32
Recruiting26
unknown14
Terminated12
Active, not recruiting8
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
98
Active
34
Success Rate
72.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.8%)
Phase 117 (21.8%)
Phase 239 (50.0%)
Phase 33 (3.8%)
Phase 42 (2.6%)
N/A14 (17.9%)

Trials by Status

enrolling_by_invitation11%
not_yet_recruiting33%
terminated1212%
withdrawn22%
active_not_recruiting88%
recruiting2627%
completed3233%
unknown1414%

Recent Activity

Clinical Trials (98)

Showing 20 of 98 trialsScroll for more
NCT06487481Phase 1

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Recruiting
NCT06800339Phase 1

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

Recruiting
NCT05546827Phase 2

Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma

Recruiting
NCT03772119

Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children

Recruiting
NCT01871766Phase 2

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Active Not Recruiting
NCT07549399Phase 3

SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC

Not Yet Recruiting
NCT04968990Phase 2

Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation

Recruiting
NCT06239272Phase 1

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Recruiting
NCT01857934Phase 2

Therapy for Children With Advanced Stage Neuroblastoma

Completed
NCT07340151Not Applicable

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Recruiting
NCT04938609Phase 2

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Active Not Recruiting
NCT04545814Not Applicable

Analyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain Metastases

Completed
NCT02114229Phase 2

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Active Not Recruiting
NCT06186401Phase 1

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Recruiting
NCT06504381Phase 1

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Recruiting
NCT06492954Phase 1

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

Recruiting
NCT03174275Phase 2

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

Active Not Recruiting
NCT07410715

Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)

Not Yet Recruiting
NCT05535166Phase 2

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Recruiting
NCT05129787Not Applicable

Ablation vs Resection of Colorectal Cancer Liver Metastases

Active Not Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
98